INM Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-01-14 | HULL ANDREW | director | 8,542 | H-ExpireLong | D | 42 | 307.01 | 12,894.00 |
| 2024-03-04 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 52,545 | H-ExpireLong | D | 309 | 364.72 | 112,698.00 |
| 2024-01-21 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 52,485 | H-ExpireLong | D | 121 | 312.73 | 37,840.00 |
| 2024-02-20 | Jagpal Netta | officer: Chief Financial Officer | 0 | D | 50,000 | 0.37 | 18,500.00 | |
| 2024-02-21 | HULL ANDREW | director | 38,258 | P-Purchase | A | 37,500 | 0.39 | 14,625.00 |
| 2024-02-20 | ADAMS ERIC A | director, officer: President & CEO | 43,959 | P-Purchase | A | 41,600 | 0.36 | 14,922.00 |
| 2023-12-23 | Johnson Shane Aaron | officer: Sr VP & General Manager | 48,000 | A-Award | A | 40,000 | 0.37 | 14,800.00 |
| 2023-12-23 | Lemerond Nicole | director | 8,500 | A-Award | A | 7,100 | 0.37 | 2,627.00 |
| 2023-12-23 | WOUDENBERG MICHAEL | officer: Chief Operating Officer | 75,494 | A-Award | A | 65,000 | 0.37 | 24,050.00 |
| 2023-12-23 | Tegge Jonathan | officer: Interim CFO | 31,400 | A-Award | A | 30,000 | 0.37 | 11,100.00 |
| 2023-12-23 | Grove Janet P | director | 8,500 | A-Award | A | 7,100 | 0.37 | 2,627.00 |
| 2023-12-23 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 52,854 | A-Award | A | 45,000 | 0.37 | 16,650.00 |
| 2023-12-23 | ADAMS ERIC A | director, officer: President & CEO | 162,139 | A-Award | A | 136,000 | 0.37 | 50,320.00 |
| 2023-12-23 | Baldasare Bryan T | director | 8,500 | A-Award | A | 7,100 | 0.37 | 2,627.00 |
| 2023-12-23 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 52,606 | A-Award | A | 45,000 | 0.37 | 16,650.00 |
| 2023-12-23 | HULL ANDREW | director | 8,584 | A-Award | A | 7,100 | 0.37 | 2,627.00 |
| 2023-12-05 | WOUDENBERG MICHAEL | officer: Chief Operating Officer | 10,494 | H-ExpireLong | D | 848 | 270.36 | 229,265.00 |
| 2023-08-31 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 7,854 | H-ExpireLong | D | 327 | 499.96 | 163,487.00 |
| 2023-05-16 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 8,181 | H-ExpireLong | D | 152 | 623.93 | 94,837.00 |
| 2023-05-16 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 7,606 | H-ExpireLong | D | 485 | 623.93 | 302,606.00 |
| 2023-05-16 | ADAMS ERIC A | director, officer: President & CEO | 26,139 | H-ExpireLong | D | 1,818 | 623.93 | 1,134,305.00 |
| 2023-03-08 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 8,091 | H-ExpireLong | D | 61 | 927.64 | 56,586.00 |
| 2023-03-08 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 8,333 | H-ExpireLong | D | 545 | 927.64 | 505,564.00 |
| 2023-03-08 | ADAMS ERIC A | director, officer: President & CEO | 27,957 | H-ExpireLong | D | 545 | 927.64 | 505,564.00 |
| 2022-12-16 | Lemerond Nicole | director | 1,400 | A-Award | A | 840 | 0.00 | 0.00 |
| 2022-12-16 | Tegge Jonathan | officer: Interim CFO | 1,400 | A-Award | A | 1,400 | 0.00 | 0.00 |
| 2022-12-16 | Li Sarah | officer: VP Accounting & Controller | 4,002 | A-Award | A | 3,600 | 0.00 | 0.00 |
| 2022-12-16 | Johnson Shane Aaron | officer: Sr VP & General Manager | 8,000 | A-Award | A | 4,200 | 0.00 | 0.00 |
| 2022-12-16 | WOUDENBERG MICHAEL | officer: Chief Operating Officer | 11,342 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2022-12-16 | Grove Janet P | director | 1,400 | A-Award | A | 840 | 0.00 | 0.00 |
| 2022-12-16 | HULL ANDREW | director | 1,484 | A-Award | A | 840 | 0.00 | 0.00 |
| 2022-12-16 | Baldasare Bryan T | director | 1,400 | A-Award | A | 840 | 0.00 | 0.00 |
| 2022-12-16 | ADAMS ERIC A | officer: President & CEO | 28,502 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2022-12-16 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 8,878 | A-Award | A | 4,200 | 0.00 | 0.00 |
| 2022-12-16 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 8,152 | A-Award | A | 4,200 | 0.00 | 0.00 |
| 2022-12-12 | Tegge Jonathan | None | 0 | None | None | 0.00 | ||
| 2022-12-12 | Tegge Jonathan | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-11-16 | Li Sarah | officer: VP, Accounting and Controller | None | D | 80 | 35.00 | 2,800.00 | |
| 2022-11-14 | Johnson Shane Aaron | officer: Sr VP & General Manager | 3,800 | D-Return | D | 4,200 | 0.00 | 0.00 |
| 2022-11-14 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 3,952 | D-Return | D | 4,200 | 0.00 | 0.00 |
| 2022-11-14 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 4,678 | D-Return | D | 4,200 | 0.00 | 0.00 |
| 2022-11-14 | ADAMS ERIC A | officer: President & CEO | 13,502 | D-Return | D | 15,000 | 0.00 | 0.00 |
| 2022-11-14 | WOUDENBERG MICHAEL | officer: Chief Operating Officer | 3,842 | D-Return | D | 7,500 | 0.00 | 0.00 |
| 2022-11-14 | Johnson Shane Aaron | officer: Sr. VP & General Manager | 8,000 | A-Award | A | 4,200 | 0.00 | 0.00 |
| 2022-11-14 | WOUDENBERG MICHAEL | officer: Chief Operating Officer | 11,342 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2022-11-14 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 8,878 | A-Award | A | 4,200 | 0.00 | 0.00 |
| 2022-11-14 | ADAMS ERIC A | officer: President & CEO | 28,502 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2022-11-14 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 8,152 | A-Award | A | 4,200 | 0.00 | 0.00 |
| 2022-08-10 | Lemerond Nicole | director: | 14,000 | A-Award | A | 14,000 | 0.00 | 0.00 |
| 2022-08-08 | Lemerond Nicole | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-06-02 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 98,787 | H-ExpireLong | D | 1,515 | 0.00 | 0.00 |
| 2022-06-02 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 98,787 | H-ExpireLong | D | 1,515 | 11.75 | 17,801.00 |
| 2022-06-02 | ADAMS ERIC A | officer: President & CEO | 337,576 | H-ExpireLong | D | 13,636 | 0.00 | 0.00 |
| 2022-05-17 | Baldasare Bryan T | director: | 14,000 | A-Award | D | 14,000 | 0.00 | 0.00 |
| 2022-05-17 | Baldasare Bryan T | director | 14,000 | A-Award | D | 14,000 | 0.80 | 11,200.00 |
| 2022-05-12 | Baldasare Bryan T | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-04-14 | ADAMS ERIC A | officer: President & CEO | 59,003 | P-Purchase | A | 14,160 | 0.89 | 12,659.00 |
| 2022-04-13 | ADAMS ERIC A | officer: President & CEO | 44,843 | P-Purchase | A | 8,560 | 0.85 | 7,276.00 |
| 2022-04-01 | Edwards Brenda | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-02-23 | WOUDENBERG MICHAEL | officer: See Remarks | 96,060 | A-Award | A | 5,000 | 1.01 | 5,050.00 |
| 2022-02-20 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 100,302 | H-ExpireLong | D | 3,030 | 9.59 | 29,058.00 |
| 2022-02-18 | Grove Janet P | director | 14,000 | A-Award | A | 14,000 | 1.12 | 15,680.00 |
| 2022-02-11 | Grove Janet P | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-01-24 | Garner William J | director | 16,122 | H-ExpireLong | D | 24,242 | 3.42 | 82,908.00 |
| 2022-01-24 | ADAMS ERIC A | director, officer: President & CEO | 411,818 | H-ExpireLong | D | 60,606 | 2.10 | 127,273.00 |
| 2022-01-24 | ADAMS ERIC A | director, officer: President & CEO | 351,212 | H-ExpireLong | D | 60,606 | 2.89 | 175,151.00 |
| 2022-01-24 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 103,332 | H-ExpireLong | D | 12,121 | 5.13 | 62,181.00 |
| 2022-01-24 | HULL ANDREW | director | 16,122 | H-ExpireLong | D | 30,303 | 2.89 | 87,576.00 |
| 2022-01-24 | Cutler Adam D. | director | 40,364 | H-ExpireLong | D | 6,061 | 3.82 | 23,153.00 |
| 2022-01-24 | Cutler Adam D. | director | 38,849 | H-ExpireLong | D | 1,515 | 3.68 | 5,575.00 |
| 2022-01-24 | Cutler Adam D. | director | 16,122 | H-ExpireLong | D | 22,727 | 2.89 | 65,681.00 |
| 2022-01-24 | COLWILL BRUCE | officer: CFO | 11,515 | P-Purchase | A | 5,000 | 1.09 | 5,438.00 |
| 2022-01-06 | Johnson Shane Aaron | officer: SVP, GM of BayMedica LLC | 304,595 | P-Purchase | A | 8,500 | 1.26 | 10,710.00 |
| 2021-12-30 | Johnson Shane Aaron | officer: SVP, GM of BayMedica LLC | 296,095 | P-Purchase | A | 8,093 | 1.33 | 10,736.00 |
| 2021-12-29 | Sazdanoff Catherine | director | 29,091 | A-Award | A | 7,000 | 1.32 | 9,240.00 |
| 2021-12-29 | HULL ANDREW | director | 46,425 | A-Award | A | 7,000 | 1.32 | 9,240.00 |
| 2021-12-29 | Garner William J | director | 40,364 | A-Award | A | 7,000 | 1.32 | 9,240.00 |
| 2021-12-29 | Cutler Adam D. | director | 46,425 | A-Award | A | 7,000 | 1.32 | 9,240.00 |
| 2021-11-15 | Johnson Shane Aaron | officer: SVP, GM of BayMedica LLC | 288,002 | P-Purchase | A | 5,000 | 1.37 | 6,845.00 |
| 2021-11-02 | Johnson Shane Aaron | officer: SVP & GM of BayMedica LLC | 278,428 | I | 0 | 0.00 | 0.00 | |
| 2021-11-02 | Johnson Shane Aaron | officer: SVP & GM of BayMedica LLC | 4,574 | D | 0 | 0.00 | 0.00 | |
| 2021-11-02 | Johnson Shane Aaron | officer: SVP & GM of BayMedica LLC | 0 | D | 35,000 | 1.40 | 49,000.00 | |
| 2021-10-18 | WOUDENBERG MICHAEL | officer: VP, Chem/Manufacturing/Control | 91,060 | A-Award | A | 30,000 | 1.40 | 42,000.00 |
| 2021-10-18 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 116,969 | A-Award | A | 35,000 | 1.40 | 49,000.00 |
| 2021-10-18 | ADAMS ERIC A | director, officer: President & CEO | 472,424 | A-Award | A | 125,000 | 1.40 | 175,000.00 |
| 2021-10-18 | COLWILL BRUCE | officer: CFO | 150,303 | A-Award | A | 60,000 | 1.40 | 84,000.00 |
| 2021-10-18 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 115,453 | A-Award | A | 35,000 | 1.40 | 49,000.00 |
| 2021-09-29 | ADAMS ERIC A | director, officer: President & CEO | 36,283 | P-Purchase | A | 8,800 | 1.73 | 15,224.00 |
| 2021-09-28 | ADAMS ERIC A | director, officer: President & CEO | 27,483 | P-Purchase | A | 11,400 | 1.75 | 19,984.00 |
| 2021-09-28 | COLWILL BRUCE | officer: CFO | 6,515 | P-Purchase | A | 5,000 | 1.77 | 8,840.00 |
| 2020-12-16 | WOUDENBERG MICHAEL | officer: VP, Chem/Manufacturing/Control | 30,000 | A-Award | A | 30,000 | 3.02 | 90,600.00 |
| 2020-12-16 | Sazdanoff Catherine | director | 11,000 | A-Award | A | 11,000 | 3.02 | 33,220.00 |
| 2020-12-16 | Sazdanoff Catherine | director | 7,000 | A-Award | A | 7,000 | 3.02 | 21,140.00 |
| 2020-12-16 | MANCINI ALEXANDRA DIANE JANET | officer: Sr VP, Clinical Reg Affairs | 35,000 | A-Award | A | 35,000 | 3.02 | 105,700.00 |
| 2020-12-16 | HULL ANDREW | director | 7,000 | A-Award | A | 7,000 | 3.02 | 21,140.00 |
| 2020-12-16 | HSU ERIC C | officer: Sr. VP, Pre-Clinical Res/Dev | 35,000 | A-Award | A | 35,000 | 3.02 | 105,700.00 |
| 2020-12-16 | Garner William J | director | 7,000 | A-Award | A | 7,000 | 3.02 | 21,140.00 |
| 2020-12-16 | Cutler Adam D. | director | 7,000 | A-Award | A | 7,000 | 3.02 | 21,140.00 |
| 2020-12-16 | COLWILL BRUCE | officer: CFO | 60,000 | A-Award | A | 60,000 | 3.02 | 181,200.00 |
| 2020-12-16 | ADAMS ERIC A | director, officer: President & CEO | 125,000 | A-Award | A | 125,000 | 3.02 | 377,500.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
